Back

Aspirin after stenting - Do we still need it?

27 August 2018 (12:07 - 12:30)
Organised by:
Congress Presentation Part of: Safer stents and strategies: is it time for the de-escalation of dual antiplatelet treatment regimes? Stents ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Gilles Montalescot

Sorbonne University, Paris (France)

3 More presentations in this session

Presentation thumbnail
De-escalation of dual antiplatelet therapy intensity in acute coronary syndrome.
Professor S. Schuepke (Munich, DE)
Slides Video
Presentation thumbnail
Stent type and duration of dual antiplatelet therapy.
Professor T. Kimura (Hirakata, JP)
Slides Video
Presentation thumbnail
De-escalation antithrombotic therapy in stented patients with atrial fibrillation.
Professor D. Angiolillo (Jacksonville, US)
Slides Video

Access the full session

Session thumbnail
Safer stents and strategies: is it time for the de-escalation of dual antiplatelet treatment regimes?

The Event

Event poster

ESC Congress 2018

27 August 2018 12:07 CET
You may be interested in
thumbnail
Congress Session
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
28 August 2023
thumbnail
Congress Presentation
Safety of dual antiplatelet pre-treatment in ACS patients undergoing unplanned aortocoronary bypass surgery
15 March 2025
thumbnail
Congress Presentation
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
1 September 2025
thumbnail
Congress Presentation
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources